AB 2876: Corrections
- Session Year: 2019-2020
- House: Assembly
- Latest Version Date: 2020-07-08
|
Date
|
Status
|
|---|---|
| Aug 20, 2020 | In committee: Held under submission. |
| Aug 17, 2020 | In committee: Referred to APPR. suspense file. |
| Aug 8, 2020 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 7. Noes 0.) (August 7). Re-referred to Com. on APPR. |
| Jul 29, 2020 | In committee: Set, first hearing. Hearing canceled at the request of author. |
| Jul 8, 2020 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on PUB. S. |
| Jul 2, 2020 | Re-referred to Com. on PUB. S. |
| Jun 29, 2020 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on RLS. |
| Jun 23, 2020 | Referred to Com. on RLS. |
| Jun 11, 2020 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Jun 10, 2020 | Read third time. Passed. Ordered to the Senate. (Ayes 78. Noes 0. Page 4772.) |
| Jun 4, 2020 | Read second time. Ordered to third reading. |
| Jun 3, 2020 | From committee: Do pass. (Ayes 18. Noes 0.) (June 3). |
| Jun 2, 2020 | In committee: Set, first hearing. Referred to APPR. suspense file. |
| May 19, 2020 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (May 18). Re-referred to Com. on APPR. |
| May 5, 2020 | Re-referred to Com. on HEALTH. |
| May 4, 2020 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Apr 24, 2020 | Referred to Com. on HEALTH. |
| Feb 24, 2020 | Read first time. |
| Feb 22, 2020 | From printer. May be heard in committee March 23. |
| Feb 21, 2020 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 17, 2020 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Aug 7, 2020 | Do pass, but first be re-referred to the Committee on [Appropriations] | Senate Standing Committee on Public Safety |
Passed |
|
| Jun 10, 2020 | AB 2876 Waldron Assembly Third Reading | Assembly Floor |
Passed |
|
| Jun 3, 2020 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| May 18, 2020 | Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
SENATE COMMITTEE ON APPROPRIATIONS
Senator Anthony Portantino, Chair
2019 - 2020 Regular Session
AB 2876 (Waldron) - Corrections
Version: July 8, 2020 | Policy Vote: PUB. S. 7 - 0 |
Urgency: Yes | Mandate: No |
Hearing Date: August 17, 2020 | Consultant: Shaun Naidu |
Bill Summary:
AB 2876, an urgency measure, would establish an emergency preparedness taskforce within the Department of Corrections and Rehabilitation (CDCR) and to extend the sunset of the Supervised Population Workforce Training Grant Program (SPWTFP).
Fiscal Impact:
- CDCR: Unknown costs to operate an emergency preparedness taskforce but potentially in the low millions of dollars annually for the life of the task force. The department’s operating costs for the Council on Criminal Justice and Behavioral Health, for purposes of comparison, is approximately $1.2 million annually with 3.0 personnel. (General Fund)
- California Workforce Development Board (CWDB): Unknown, potentially-significant cost pressures related to the extension of SPWTFP. State operations costs would depend on the number of grants and the funding amount available for grantees. If, for example, there was a $10 million appropriation for SPWTFP, it would fund roughly 30 grants and require an estimated staffing cost to the board of $365,000 for the life of the program. Presuming the funding for the grants would be appropriated from the General Fund, staff costs also would be included. (General Fund)
All funds allocated for SPWTFP to date have been expended, and CWDB closed out the program at the end of March 2020.
Background:
As stated in the analysis of this bill by the Senate Committee on Public Safety:
The Supervised Population Workforce Training Grant Program was established by AB 2060 (Chapter 383, Statutes of 2014, V. Manuel Pérez). The grant program is administered by the California Workforce Development Board and was created to support Governor Brown’s public safety realignment efforts.
SPWTGP is a pilot designed to improve employment outcomes for the supervised population which faces significant barriers to employment, including limited education and job skills, substance abuse issues, mental health issues, and limited access to stable housing. Initially, eligible participants were limited to populations that are supervised by county probation departments, such as individuals on probation, mandatory supervision, and post-release community supervision. Eligibility was subsequently expanded to include those on parole and under the jurisdiction of CDCR. Improved employment outcomes are achieved “by effectively aligning training, education, and intensive services, in tandem with outreach to employers in growing industries receptive to hiring individuals with criminal backgrounds.” (California Workforce Development Board, AB 2060 Initiative: Supervised Workforce Training Grant Program: Interim Report to the California Legislature (2018), p. 2 <https://cwdb.ca.gov/wp-content/uploads/sites/43/2018/04/AB-2060-Report-032018-FINAL-SAR-signed.pdf>.) More specifically:
The AB 2060 approach focuses on developing or expanding collaboration with probation departments as key partners in the case management of formerly incarcerated job seekers. Grantees are required to bring together service delivery partners, at minimum the local workforce development board and county probation, to coordinate services and test placement opportunities in growing industries. Additional eligible project partners include community colleges, adult schools, and community-based organizations (CBOs). These partnerships then work together to align education, training, case management, employer engagement, job placement, and job retention support services to ultimately improve the labor market outcomes of their formerly incarcerated participants. (Ibid.)
CWDB’s 2018 interim report on the grant program concluded that “AB 2060 grantees are succeeding in providing training in priority occupations and improving the labor market and skills outcomes for participating formerly incarcerated job-seekers.” (Id. at p. 11.)
Proposed Law:
This bill would:
- Establish an emergency preparedness task force within CDCR, as specified.
- Require the task force to evaluate the preparedness of the correctional system and to report and make recommendations quarterly to the Legislature, Governor’s office, and the Department of Finance.
- Allow the task force to issue competitive grants to nonprofit entities and organizations pursuant to adopted regulations.
- Extend SPWTFP until January 1, 2026.
Related Legislation:
AB 2061 (Waldron, Ch. 100, Stats. 2016) established an additional SPWTGP priority for applications that include one or more employers who have demonstrated interest in employing individuals in the supervised population, including “earn and learn” opportunities, and intent to hire and expanded the areas of the final program assessment to include whether the SPWTGP provided training opportunities in areas related to work skills learned while incarcerated, including while working with the Prison Industry Authority.
AB 2060 (V. Manuel Perez, Ch. 383, Stats. 2014) established the Supervised Population Workforce Training Grant Program.
Staff Comments:
This bill would include in the duties of the task force an evaluation of CDCR’s preparedness for future emergencies and disasters, including viral outbreaks, natural disasters, civil insurrection, war or imminent attacks. Evaluation of the department’s planned responses to many, if not all, of those types of incidents likely would require the review confidential information that the department does not disclose for security (of the public, staff, and incarcerated individuals) purposes. The author may wish to consider the appropriateness of non-departmental entities accessing and reviewing such sensitive information and data, and absent such access, the value of the task force in evaluating and making recommendations on CDCR’s emergency and disaster preparedness.
-- END --
SENATE COMMITTEE ON PUBLIC SAFETY
Senator Nancy Skinner, Chair
2019 - 2020 Regular
Bill No: AB 2876 Hearing Date: August 7, 2020
Author: | Waldron | ||
Version: | July 8, 2020 | ||
Urgency: | Yes | Fiscal: | Yes |
Consultant: | SJ | ||
Subject: Corrections
HISTORY
Source: Author
Prior Legislation: SB 106 (Comm. on Budget and Fiscal Rev.), Ch. 96, Stats. 2017
AB 2061 (Waldron), Ch. 100, Stats. 2016
AB 2060 (V. Manuel Pérez), Ch. 383, Stats. 2014
Support: American Conservative Union Foundation; Anti-Recidivism Coalition; California Public Defenders Association; Californians for Safety and Justice; #cut 50; Reform Alliance; Social Change
Opposition: None known
Assembly Floor Vote: Not relevant
PURPOSE
The purpose of this bill is to establish an emergency preparedness taskforce within the Department of Corrections and Rehabilitation (CDCR) and to extend the sunset of the Supervised Population Workforce Training Grant Program.
Existing law establishes CDCR to administer the state prison system under the direction of the Secretary. (Pen. Code, § 5000 et seq.)
Existing law establishes the California Workforce Development Board (CWDB). (Unemp. Ins. Code, § 14010 et seq.)
Existing law establishes the Supervised Population Workforce Training Grant Program (SPWTGP) to be administered by the CWDB. (Pen. Code, §1234.1.)
Existing law requires the grant program to be designed and implemented according to specified criteria. Delineates how the grant program is to be administered. (Pen. Code, §§ 1234.1-1234.3.)
Existing law provides that this program sunsets on January 2, 2021. (Pen. Code, § 1234.5.)
This bill requires the Secretary of CDCR, or the secretary’s designee, to convene and chair an emergency preparedness task force within the department.
This bill requires members of the task force to be appointed by the chair and to include all of the following:
- A representative from CDCR.
- A representative from the California Correctional Peace Officers Association.
- Currently and formerly incarcerated persons.
- A representative from the Dream Corp’s #Cut50 program.
- A representative from the Anti-Recidivism Coalition.
- A representative from the American Conservative Union.
- A representative from Californians for Safety and Justice.
- A representative from the REFORM Alliance.
- The Director of the Division of Adult Parole Operations, or the director’s designee.
- A person representing county probation officers.
- A person representing county sheriff’s departments.
- Persons representing the physical and behavioral health professions.
This bill provides that the duties of the task force include evaluating preparedness in the correctional system for future emergencies or disasters, including viral outbreaks, natural disasters, civil insurrection, war or imminent attacks, and to make recommendations for improvement.
This bill requires the task force to report its initial finding to the Legislature, Governor’s Office, and the Department of Finance at the earliest date possible, but no later than January 1, 2021, and report its ongoing findings quarterly thereafter no later than April 1, July 1, October 1, and January 1, of each year. Requires these reports submitted pursuant to be submitted in compliance with Section 9795 of the Government Code.
This bill requires the recommendations of the task force to focus on all of the following:
- Capital outlay, physical improvements, and technology upgrades at correctional facilities.
- Continuity of programming and services, including education and enrichment activities, health care and behavioral health care services, and communications with family and others during times of disaster or emergency.
- Supplies, including sanitary, medical, and other safety supplies.
- Alternatives to incarceration for low-level crimes and technical violations, as well as strategies to safely reduce the overall prison population.
- Prison closures.
- Other recommendations, as appropriate for the health and safety of prisoners, prison staff, and the general public.
This bill authorizes the task force to award competitive grants to nonprofit entities during times of disasters and nonprofit service organizations whose work furthers the recommendations of the task force, subject to a future appropriation made for this purpose.
This bill requires the chair of the task force to adopt regulations for the implementation of the competitive grant program. Requires the regulations to include all of the following:
- Specific eligibility qualifications for the grant.
- Application procedures.
- Selection criteria.
- A requirement that each grant recipient submit a written report to the task force documenting its expenditures of the grant funds and results of the funded project.
- Provisions promoting the equitable distribution of grant funds to various nonprofit organizations throughout the state, with the goal of making grants available to organizations that will further the task force’s recommendations.
This bill extends the sunset of the SPWTGP until January 1, 2026.
This bill contains an urgency clause.
COMMENTS
- Need for This Bill
According to the author:
The COVID-19 pandemic brings into focus the serious threat that natural disasters, pandemics, and other emergencies can inflict on the incarcerated population and criminal justice operations in our state. More than ever before, it is critical that we bring key stakeholders together to provide needed input to shape California’s criminal justice system. California must act now to ensure better planning for future disasters and emergencies, thereby protecting the health and safety of incarcerated persons, correctional staff, and our communities.
- CDCR Emergency Preparedness Taskforce
This bill requires the Secretary of CDCR to establish and chair an emergency preparedness taskforce. The purpose of the task force is to evaluate emergency preparedness in the state prison system for future emergencies or disasters, including viral outbreaks, natural disasters, civil insurrection, war or imminent attacks, and to make recommendations for improvement. The bill specifies the individuals that must be included on the task force in addition to the Secretary or the Secretary’s designee: a representative from CDCR, a representative from the CCPOA, currently and formerly incarcerated individuals, representatives from five specific community organizations, the Director of DAPO, a person representing county probation officers, a person representing county sheriff’s departments, and individuals representing the physical and behavioral health professions. The task force would be required to report its findings quarterly beginning January 1, 2021 to the Legislature, Governor’s Office, and the Department of Finance. Additionally, the bill authorizes the task force to award competitive grants to nonprofit organizations during times of disasters and to nonprofit service organizations whose work furthers the recommendations of the task force, and requires the chair of the task force to adopt regulations to implement the grant program.
This bill was introduced in response to the ongoing COVID-19 pandemic which has significantly impacted the state’s prisons. Specifically, there have been several outbreaks at a number of the state’s prisons, impacting both inmates and staff and arguably the communities in which those prisons are located. Many advocates as well as members of the Legislature believe that a more collaborative approach between the administration and relevant stakeholders is necessary in order to effectively manage COVID-19 in the state’s prisons as well as to prepare for future emergencies. This bill contains an urgency clause due to the current COVID-19 emergency.
Notably, the task force membership provision of the bill includes representatives from specific named community organizations. Although representatives of specific government agencies and associations related to government agencies are often named in statutes created task forces, commissions, councils, boards, and other advisory bodies, specific community organizations are generally not named in statute. General descriptors for those kinds of organizations are typically used instead.
- Supervised Population Workforce Training Grant Program
The Supervised Population Workforce Training Grant Program was established by AB 2060 (Chapter 383, Statutes of 2014, V. Manuel Pérez). The grant program is administered by the California Workforce Development Board and was created to support Governor Brown’s public safety realignment efforts.
SPWTGP is a pilot designed to improve employment outcomes for the supervised population which faces significant barriers to employment, including limited education and job skills, substance abuse issues, mental health issues, and limited access to stable housing. Initially, eligible participants were limited to populations that are supervised by county probation departments, such as individuals on probation, mandatory supervision, and post-release community supervision. Eligibility was subsequently expanded to include those on parole and under the jurisdiction of CDCR. Improved employment outcomes are achieved “by effectively aligning training, education, and intensive services, in tandem with outreach to employers in growing industries receptive to hiring individuals with criminal backgrounds.” (California Workforce Development Board, AB 2060 Initiative: Supervised Workforce Training Grant Program: Interim Report to the California Legislature (2018), p. 2 <https://cwdb.ca.gov/wp-content/uploads/sites/43/2018/04/AB-2060-Report-032018-FINAL-SAR-signed.pdf>.) More specifically:
The AB 2060 approach focuses on developing or expanding collaboration with probation departments as key partners in the case management of formerly incarcerated job seekers. Grantees are required to bring together service delivery partners, at minimum the local workforce development board and county probation, to coordinate services and test placement opportunities in growing industries. Additional eligible project partners include community colleges, adult schools, and community-based organizations (CBOs). These partnerships then work together to align education, training, case management, employer engagement, job placement, and job retention support services to ultimately improve the labor market outcomes of their formerly incarcerated participants. (Ibid.)
CWDB’s 2018 interim report on the grant program concluded that “AB 2060 grantees are succeeding in providing training in priority occupations and improving the labor market and skills outcomes for participating formerly incarcerated job-seekers.” (Id. at p. 11.) This bill extends the sunset of the SPWTGP to January 1, 2026.
-- END --
ASSEMBLY THIRD READING
ATR Bill Id:AB 2876
Author:(Waldron)
As Amended Ver:May 4, 2020
Majority vote
SUMMARY:
Requires the Department of Health Care Services (DHCS) to report to the Legislature on or before January 10, 2022, specified information regarding the California Medication Assisted Treatment Program Expansion Project (MAT Expansion Project), including among other things, the number of patients, by county, treated through the program. Repeals this reporting requirement on January 1, 2024.
Major Provisions
COMMENTS:
- MAT. MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a "whole-patient" approach to the treatment of SUDs. Research shows that a combination of medication and therapy can successfully treat these disorders, and for some people struggling with addiction, MAT can help sustain recovery.
MAT is primarily used for the treatment of addiction to opioids such as heroin and prescription pain relievers that contain opiates. The prescribed medication operates to normalize brain chemistry, block the euphoric effects of alcohol and opioids, relieve physiological cravings, and normalize body functions without the negative effects of the abused drug. Medications used in MAT are approved by the federal Food and Drug Administration, and include methadone, buprenorphine and naltrexone (Vivitrol). MAT programs are clinically driven and tailored to meet each patient's needs.
MAT is proven to be clinically effective and to significantly reduce the need for inpatient detoxification services. MAT provides a more comprehensive, individually tailored program of medication and behavioral therapy. MAT also includes support services that address the needs of most patients. The ultimate goal of MAT is full recovery including the ability to live a self-directed life.
- Medi-Cal MAT. Individuals eligible for Medi-Cal may obtain MAT through the Drug Medi-Cal-Organized Delivery System (DMC-ODS) where counties have opted in or through the DMC Program for all other counties. Forty counties have opted into the DMC-ODS and have DHCS-approved implementation plans. According to the DHCS' 2019 Evaluation Report, as of July 1, 2019, DMC-ODS had been implemented in counties containing the vast majority (93.5%) of California's population but a few small/rural counties are still not participating. The goal of the DMC-ODS is to demonstrate how organized SUD care improves beneficiary health outcomes, while decreasing system-wide health care costs. Counties that opt into the DMC-ODS waiver are required to provide methadone, buprenorphine, disulfiram and naloxone in narcotic treatment program (NTP) setting and may also offer additional MAT, such as buprenorphine and naltrexone at DMC facilities. All other counties are part of the DMC Program which operates as a "carved-out" of the broader Medi-Cal program and is administered by DHCS and operated under federal waivers approved by the Centers for Medicine and Medicaid Services.
- MAT Certification. In California, MAT is commonly provided through NTPs licensed by DHCS. Physicians must be certified by the Substance Abuse and Mental Health Administration Services (SAMHSA) as a MAT provider. Under DATA 2000, qualified physicians may apply for waivers to treat opioid dependency with approved medications in any settings in which they are qualified to practice, including an office, community hospital, health department, or correctional facility. Qualified physicians are permitted to dispense or prescribe specifically approved Schedule III, IV, and V narcotic medications (medications that have a lower risk for abuse, like buprenorphine) in settings other than an NTP, such as a methadone clinic. A "qualifying physician" is specifically defined in the DATA 2000 as one who is:
- Licensed under state law;
- Registered with the Drug Enforcement Administration to dispense controlled substances;
- Required to treat no more than 30 patients at a time within the first year; and,
- Qualified by training and/or certification.
In order to maintain a waiver, a physician must be capable of referring patients to counseling and other services. Initially a physician is limited to providing MAT to no more than 30 patients at a time within the first year. Following the first year, physicians may apply to increase the number of patients to 100 and up to 275 per year in subsequent years. Physicians must apply to SAMHSA to increase their patient limits.
- Availability of MAT in California. More than 900,000 physicians in the United States can write a prescription for painkillers but fewer than 32,000 physicians are authorized to prescribe buprenorphine. Currently, there are only a little over 1,000 authorized MAT providers in California. In 2016, 48% of the counties in California did not have NTPs. In 36 California counties, opioid prescriptions exceed the national average of 640 morphine milligram equivalents per resident, which are enough opioids to medicate every resident around the clock for almost three weeks every year.
- MAT Expansion Project: In an effort to address the opioid epidemic throughout the state, DHCS implemented the MAT Expansion Project beginning in 2017. The MAT Expansion Project aims to increase access to MAT, reduce unmet treatment need, and reduce opioid overdose related deaths through the provision of prevention, treatment, and recovery activities. The project focuses on populations with limited MAT access, including rural areas and American Indian & Alaska Native tribal communities. The MAT Expansion Project is funded by grants from the SAMHSA and is composed of nearly 30 projects. In April 2017, DHCS received the State Targeted Response to the Opioid Crisis Grant. The MAT Expansion Project consists of three primary components: a) The California Hub and Spoke System (CA H&SS); b) An increase in the availability and utilization of buprenorphine statewide, and, c) The Tribal MAT Project.
In September 2018, DHCS received the State Opioid Response (SOR) Grant. With SOR funding, DHCS implemented the MAT Expansion Project 2.0. The MAT Expansion Project 2.0 focuses on the following key objectives: a) Increased access to MAT; b) Reduction in unmet treatment needs; and, c) Reduction in opioid overdose related deaths through prevention, treatment, and recovery services. In accomplishing those objectives, the program works toward the following goal:
- Develop additional MAT locations through strategic access points;
- Provide MAT services to specialized or underserved populations;
- Transform entry points to individuals with an opioid use disorder (OUD) and create effective referrals into treatment and develop coordinated referral processes to better manage high-risk transitions of care;
- Engage prospective and current prescribers to increase provision of MAT; and,
- Enact overdose prevention activities to prevent opioid misuse and overdose deaths.
The SOR Grant Performance Progress Report details the activities, accomplishments experienced during the period of September 30, 2018 through September 29, 2019.
- There were 7,381 clients who received treatment services. Of those 7,381 clients, 1,806 received methadone; 5,144 received buprenorphine: and 431 received injectable naltrexone;
- The number of clients receiving recovery support services was 7,875; and,
- The number of naloxone kits distributed was 244,428 (from October 1, 2018 to September 29, 2019) and the number of overdose reversals was 7,458.
Over the course of two years, the MAT Expansion Project has provided treatment to approximately 22,000 new patients; saved approximately 7,500 lives with opioid overdose reversal medication naloxone; created 650 new access point locations where patients can receive treatment for OUD; trained 395 new providers to prescribe buprenorphine; Established 52 hospitals and emergency rooms as centers for stabilization and referral to treatment for OUD, while initiating and referring into treatment 2,340 individuals on buprenorphine; and, expanded access to treatment in jails and drug courts in 29 counties, which have provided MAT services to 1,646 clients as a result of educational and technical assistance programming and infrastructure funding through the MAT Expansion Project.
According to the Author:
The California MAT Expansion Project has been a great boon to statewide efforts to combat opioid abuse. This bill would help ensure that relevant stakeholders and key decision makers have the information they need to continue to improve and support the program.
Arguments in Support:
The Drug Policy Alliance states that this bill would help ensure that all Californians have equal access to the lifesaving benefits of MAT. The bill would allow decision makers to more readily identify the areas with the highest need and to target resources to best serve those communities. Further, this bill would collect currently unavailable data regarding statewide efforts to recruit and retain medical professionals within the program.
Arguments in Opposition:
There is no known opposition.
FISCAL COMMENTS:
According to the Assembly Appropriations Committee, reporting costs are expected to be minor and absorbable (federal grant funds).
VOTES:
ASM HEALTH: 15-0-0
YES: Wood, Mayes, Aguiar-Curry, Bigelow, Bonta, Burke, Carrillo, Flora, Limón, McCarty, Nazarian, Ramos, Rodriguez, Santiago, Waldron
ASM APPROPRIATIONS: 18-0-0
YES: Gonzalez, Bigelow, Bauer-Kahan, Bloom, Bonta, Calderon, Carrillo, Chau, Megan Dahle, Diep, Eggman, Fong, Gabriel, Eduardo Garcia, Petrie-Norris, McCarty, Robert Rivas, Voepel
UPDATED:
VERSION: May 4, 2020
CONSULTANT: Judith Babcock / HEALTH / (916) 319-2097 FN: 0002891
Date of Hearing: June 2, 2020
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez, Chair
ABPCA Bill Id:AB 2876
Author:(Waldron) – As Amended Ver:May 4, 2020
Policy Committee: | Health | Vote: | 15-0 |
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill requires the Department of Health Care Services (DHCS) to report to the Legislature on or before January 10, 2022, specified information regarding the California Medication Assisted Treatment Program Expansion Project (MAT Expansion Project), including among other things, the number of patients, by county, treated through the program, and repeals this reporting requirement on January 1, 2024.
FISCAL EFFECT:
Reporting costs are expected to be minor and absorbable (federal grant funds).
COMMENTS:
- Purpose. According to the author, this bill would help ensure that relevant stakeholders and key decision makers have the information they need to continue to improve and support the MAT Expansion program.
- Background. MAT is the use of medications in combination with counseling and behavioral therapies to treat substance use disorder. MAT has been shown to be successful in treating opioid and alcohol dependency. Medications used in MAT are approved by the FDA, and include methadone, buprenorphine and naltrexone (Vivitrol).
DHCS has used targeted grants received by the federal Substance Abuse and Mental Health Administration Services (SAMHSA) to expand MAT to treat opiate addiction, including developing a “hub-and-spoke” model with centers of excellence that support community-based treatment providers to increase access to MAT. Progress reports on these grant-funded programs contain statewide data on number of patients, services provided and number of trainings provided, among other data points.
- Related Legislation. AB 2351 (Waldron) clarifies that a court may collaborate with outside organizations on a program to offer mental health and addiction treatment services (including MAT), as defined, to women who are charged in a complaint that consists only of misdemeanor offenses or who are on probation for one or more misdemeanor offenses. AB 2351 is pending in the Assembly Health Committee.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: May 18, 2020
ASSEMBLY COMMITTEE ON HEALTH
Jim Wood, Chair
ABPCA Bill Id:AB 2876
Author:(Waldron) – As Amended Ver:May 4, 2020
SUBJECT: Narcotic treatment: medication-assisted treatment.
SUMMARY: Requires the Department of Health Care Services (DHCS) to report to the Legislature on or before January 10, 2022, specified information regarding the California Medication Assisted Treatment Program Expansion Project (MAT Expansion Project), including among other things, the number of patients, by county, treated through the program. Repeals this reporting requirement on January 1, 2024. Specifically, this bill:
- Requires DHCS on or before January 10, 2022, to report to the Legislature all of the following information regarding the MAT Expansion Project:
- A summary of DHCS’s efforts to recruit and train medical professionals through the program;
- The number, name, and location of all facilities receiving funding through the program;
- The number of patients, by county, treated through the program; and,
- A medication-assisted treatment needs assessment, detailing underserved counties that would benefit from additional services or funding.
- Provides that the reporting requirement remain in effect only until January 1, 2024 and is repealed as of that date.
EXISTING LAW:
- Requires DHCS to license Narcotic Treatment Programs (NTPs) to use Narcotic Replacement Therapy (NRT) and MAT in the treatment of addicted persons whose addiction was acquired or supported by the use of alcohol or a narcotic drug or drugs, not in compliance with a physician’s legal prescription.
- Requires DHCS to establish and enforce the criteria for the eligibility of patients to be included in the programs, program operation guidelines, such as dosage levels, recordkeeping and reporting, urinalysis requirements, take-home doses of controlled substance, security against redistribution of the narcotic replacement drugs, and any other regulations that are necessary to protect the safety and well-being of the patient, the local community, and the public.
- Authorizes licensed NTPs to use the following medications for use in NRT and MAT:
- Methadone;
- Levo-alpha-acetylmethadol as specified;
- Buprenorphine products or combination of products approved by the Food and Drug Administration (FDA) for maintenance or detoxification of opioid dependence; and,
- Any other medication approved by the FDA for the purpose of NRT or MAT of substance use disorders (SUDs).
- Gives DHCS sole responsibility for compliance inspections of all programs in each county and establishes requirements for annual compliance and corrective action plans, as specified.
- Permits DHCS to license NTPs on an inpatient or outpatient basis, or both and permits DHCS to also grant a state narcotic treatment license.
- Requires the DHCS Director to suspend or revoke any NTP license, or deny an application to renew a license or to modify the terms and conditions of a license, upon any violation by the licensee that presents an imminent danger of death or severe harm to any participant of the program or a member of the general public, as specified.
- Prohibits a NTP from being authorized to use NRT and MAT without first obtaining a license as a NTP.
- Requires reimbursement to NTPs for program services to be limited to those services specified in state law and state and federal regulations governing the licensing and administration of NTPs, and requires these services to include, but not be limited to, all of the following:
- Admission, physical evaluation, and diagnosis;
- Drug screening;
- Pregnancy tests;
- NRT dosing; and,
- Intake assessment, treatment planning, and counseling services.
- Establishes the Drug Medi-Cal (DMC) program to provide medically necessary SUD treatment services to eligible Medi-Cal beneficiaries for specific, approved services. Permits DHCS to enter into contracts with each county, or enter into contracts directly with certified MAT providers, for the provision of various alcohol and drug use treatment services, including SUD services.
- Establishes the Drug Addiction Treatment Act (DATA 2000) which permits qualified physicians to provide MAT for narcotic dependence with Schedules III-V narcotic controlled substances that have been approved by the FDA for that indication.
FISCAL EFFECT: This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, the California MAT Expansion Project has been a great boon to statewide efforts to combat opioid abuse. This bill would help ensure that relevant stakeholders and key decision makers have the information they need to continue to improve and support the program.
- BACKGROUND.
- MAT. MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of SUDs. Research shows that a combination of medication and therapy can successfully treat these disorders, and for some people struggling with addiction, MAT can help sustain recovery.
MAT is primarily used for the treatment of addiction to opioids such as heroin and prescription pain relievers that contain opiates. The prescribed medication operates to normalize brain chemistry, block the euphoric effects of alcohol and opioids, relieve physiological cravings, and normalize body functions without the negative effects of the abused drug. Medications used in MAT are approved by the FDA, and include methadone, buprenorphine and naltrexone (Vivitrol). MAT programs are clinically driven and tailored to meet each patient’s needs.
MAT is proven to be clinically effective and to significantly reduce the need for inpatient detoxification services. MAT provides a more comprehensive, individually tailored program of medication and behavioral therapy. MAT also includes support services that address the needs of most patients. The ultimate goal of MAT is full recovery including the ability to live a self-directed life.
- Medi-Cal MAT. Individuals eligible for Medi-Cal may obtain MAT through the Drug Medi-Cal-Organized Delivery System (DMC-ODS) where counties have opted in or through the DMC Program for all other counties. Forty counties have opted into the DMC-ODS and have DHCS-approved implementation plans. According to the DHCS’ 2019 Evaluation Report, as of July 1, 2019, DMC-ODS had been implemented in counties containing the vast majority (93.5%) of California’s population but a few small/rural counties are still not participating. The goal of the DMC-ODS is to demonstrate how organized SUD care improves beneficiary health outcomes, while decreasing system-wide health care costs. Counties that opt into the DMC-ODS waiver are required to provide methadone, buprenorphine, disulfiram and naloxone in NTP setting and may also offer additional MAT, such as buprenorphine and naltrexone at DMC facilities. All other counties are part of the DMC Program which operates as a “carved-out” of the broader Medi-Cal program and is administered by DHCS and operated under federal waivers approved by the Centers for Medicine and Medicaid Services.
- MAT Certification. In California, MAT is commonly provided through NTPs licensed by DHCS. Physicians must be certified by the Substance Abuse and Mental Health Administration Services (SAMHSA) as a MAT provider. Under DATA 2000, qualified physicians may apply for waivers to treat opioid dependency with approved medications in any settings in which they are qualified to practice, including an office, community hospital, health department, or correctional facility. Qualified physicians are permitted to dispense or prescribe specifically approved Schedule III, IV, and V narcotic medications (medications that have a lower risk for abuse, like buprenorphine) in settings other than an NTP, such as a methadone clinic. A “qualifying physician” is specifically defined in the DATA 2000 as one who is:
- Licensed under state law;
- Registered with the Drug Enforcement Administration to dispense controlled substances;
- Required to treat no more than 30 patients at a time within the first year; and,
- Qualified by training and/or certification.
In order to maintain a waiver, a physician must be capable of referring patients to counseling and other services. Initially a physician is limited to providing MAT to no more than 30 patients at a time within the first year. Following the first year, physicians may apply to increase the number of patients to 100 and up to 275 per year in subsequent years. Physicians must apply to SAMHSA to increase their patient limits.
- Availability of MAT in California. More than 900,000 physicians in the U.S. can write a prescription for painkillers but fewer than 32,000 physicians are authorized to prescribe buprenorphine. Currently, there are only a little over 1,000 authorized MAT providers in California. In 2016, 48% of the counties in California did not have NTPs. In 36 California counties, opioid prescriptions exceed the national average of 640 morphine milligram equivalents per resident, which are enough opioids to medicate every resident around the clock for almost three weeks every year.
- The Federal Comprehensive Addiction and Recovery Act (CARA). On July 22, 2016, CARA was signed into law. One of CARA’s important previsions expanded access to SUD treatment services and overdose reversal medications including the full spectrum of services from prevention to MAT and recovery support by extending the privilege of prescribing buprenorphine in office-based settings to qualifying nurse practitioners (NP) and physician assistants (PA). SB 554 (Stone), Chapter 242, Statutes of 2017, established the buprenorphine prescribing privileges of CARA to the California NP and PA practice acts. SB 554 did not alter current state requirements that NPs and PAs only furnish or order prescription drugs under the supervision of a physician.
- MAT Expansion Project: In an effort to address the opioid epidemic throughout the state, DHCS implemented the MAT Expansion Project beginning in 2017. The MAT Expansion Project aims to increase access to MAT, reduce unmet treatment need, and reduce opioid overdose related deaths through the provision of prevention, treatment, and recovery activities. The project focuses on populations with limited MAT access, including rural areas and American Indian & Alaska Native tribal communities. The MAT Expansion Project is funded by grants from the SAMHSA and is composed of nearly 30 projects. In April 2017, DHCS received the State Targeted Response to the Opioid Crisis (Opioid STR) Grant. The MAT Expansion Project consists of three primary components: i) The California Hub and Spoke System (CA H&SS); ii) An increase in the availability and utilization of buprenorphine statewide, and, iii) The Tribal MAT Project.
In September 2018, DHCS received the State Opioid Response (SOR) Grant. With SOR funding, DHCS implemented the MAT Expansion Project 2.0. The MAT Expansion Project 2.0 focuses on the following key objectives: i) Increased access to MAT; ii) Reduction in unmet treatment needs; and, iii) Reduction in opioid overdose related deaths through prevention, treatment, and recovery services. In accomplishing those objectives, the program works toward the following goal:
- Develop additional MAT locations through strategic access points;
- Provide MAT services to specialized or underserved populations;
- Transform entry points to individuals with an opioid use disorder (OUD) and create effective referrals into treatment and develop coordinated referral processes to better manage high-risk transitions of care;
- Engage prospective and current prescribers to increase provision of MAT; and,
- Enact overdose prevention activities to prevent opioid misuse and overdose deaths.
The SOR Grant Performance Progress Report details the activities, accomplishments experienced during the period of September 30, 2018 through September 29, 2019.
- There were 7,381 clients who received treatment services. Of those 7,381 clients, 1,806 received methadone; 5,144 received buprenorphine: and 431 received injectable naltrexone;
- The number of clients receiving recovery support services was 7,875; and,
- The number of naloxone kits distributed was 244,428 (from October 1, 2018 to September 29, 2019) and the number of overdose reversals was 7,458.
Over the course of two years, the MAT Expansion Project has provided treatment to approximately 22,000 new patients; saved approximately 7,500 lives with opioid overdose reversal medication naloxone; created 650 new access point locations where patients can receive treatment for OUD; trained 395 new providers to prescribe buprenorphine; Established 52 hospitals and emergency rooms as centers for stabilization and referral to treatment for OUD, while initiating and referring into treatment 2,340 individuals on buprenorphine; and, expanded access to treatment in jails and drug courts in 29 counties, which have provided MAT services to 1,646 clients as a result of educational and technical assistance programming and infrastructure funding through the MAT Expansion Project.
- RELATED LEGISLATION. AB 2351 (Waldron) clarifies that a court may collaborate with outside organizations on a program to offer mental health and addiction treatment services (including MAT), as defined, to women who are charged in a complaint that consists only of misdemeanor offenses or who are on probation for one or more misdemeanor offenses. The bill would exclude from these provisions a woman who is charged with a felony or who is under supervision for a felony conviction. AB 2351 is pending in the Assembly Health Committee.
- PREVIOUS LEGISLATION.
- AB 1031 (Nazarian) of 2019, would have established the Youth Substance Use Disorder Treatment and Recovery Program Act of 2019. Required DHCS to establish community-based nonresidential and residential treatment and recovery programs to intervene and treat the problems of alcohol and drug use among youth under 21 years of age. AB 1031 was held in Senate Appropriations.
- AB 1557 (Chiu) of 2019, would have required DHCS to establish a three-year pilot program to provide an option to a city, county, or city and county (an entity) to receive funding to support MAT of inmates confined in a city or county jail who have a history of SUD. AB 1557 was held in Assembly Appropriations.
- AB 2384 (Arambula) of 2018, would have required a drug formulary maintained by a health care service plan, including a Medi-Cal managed plan, or health insurer to include, at a minimum, specified prescription drugs for the MAT of SUDs. AB 2384 would provide that MAT is presumed to be medically necessary, and is not subject to specified requirements of a health care service plan or policy of health insurance. AB 2384 was vetoed by the Governor.
- AB 2487 (McCarty) Chapter 301, Statutes of 2018, requires the application for a physician’s and surgeon’s certificate to include proof of satisfactory completion of a course on opiate-dependent patient treatment and management that meets the requirement, at a minimum, of CARA and also includes at least eight hours of instruction in buprenorphine treatment of opioid use disorders. AB 2487 also requires a licensed physician and surgeon to complete a continuing education course on opiate-dependent patient treatment and management unless the physician and surgeon meets the requirements of a qualifying physician within CARA.
- AB 395 (Bocanegra), Chapter 223, Statutes of 2017, added the use of MAT as an authorized service by NTPs licensed by DHCS; modified the specific controlled substances authorized for use by licensed NTPs for NRT MAT to instead allow medications approved by the FDA for the purpose of narcotic replacement treatment or MAT for SUDs; and refer to medications, rather than controlled substances.
- AB 532 (Waldron) of 2017, would have authorized a court to develop a program to offer mental health and addiction treatment services, as defined, to women charged with specified non-felony complaints. AB 532 was vetoed by the Governor.
- SB 417 (Beall) of 2009 would have established a buprenorphine MAT pilot program under DMC, commencing January 1, 2011, and concluding December 31, 2016, for the purpose of determining the efficacy of buprenorphine in treating opioid addiction. AB 417 would have required all NTPs participating in the pilot program to operate in accordance with prescribed requirements. AB 417 would also have authorized the use of buprenorphine and any other federally approved controlled substances used for the purpose of narcotic replacement treatment. AB 417 was held on the Senate Appropriations Committee suspense file.
REGISTERED SUPPORT / OPPOSITION:
Support
Drug Policy Alliance
Opposition
None on file
Analysis Prepared by: Judith Babcock / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):